Within the framework of the pharmaceutical quality system compliance in accordance with national and European requirements of GMP, the Farmak Company has successfully underwent the audit of the State Service of Ukraine on Medicinal Products and the Main Pharmaceutical Inspectorate of Poland (GIF).
The State Service of Ukraine on Medicinal Products audited warehouses, quality control laboratories and stations for finished drugs and active pharmaceutical ingredients (APIs) in terms of compliance with the Guidelines CT-N of the Ministry of Health 42 4.0: 2015 "Medicines. Good Manufacturing Practice". The audit was successfully conducted in early April. As a result of compliance with the Pharmaceutical Quality System (PQS), the Farmak Company has got 5 national GMP certificates.
In early June, the Main Pharmaceutical Inspectorate of Poland audited two stations for non-sterile drugs production in terms of compliance with the EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use. The Farmak Company exports these products to EU markets.
Inspectors highly appreciated PQS and logistical support of Farmak; they would recommend prolongation of GMP certificates. Currently, the Company is waiting for the audit reports and updated GMP certificates from the Polish regulator.
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]
The Memorandum is aimed at developing the mutual cooperation in the implementation of the state programs of the Republic of Uzbekistan for the further development of the national pharmaceutical industry. “We know the Uzbek market well and we are committed to develop cooperation. Farmak has been present in Uzbekistan since 2004. The residents of this [&hellip...